Back on July 30th, we were at .2350. That was aro
Post# of 36537
(Total Views: 308)
Posted On: 10/11/2021 1:21:50 PM
Back on July 30th, we were at .2350. That was around the time the expectation was coming for any possible news on IND. We started on a roller coaster ride soon after.
Now, we are hitting the 52 week low. Still waiting on news from a company that hasn't been forthcoming on any initiatives in months.
We have over a 1 billion dollar deal with China. We have another 1 billion dollar deal in Malaysia. We have supposedly deals for Excellagen. We have supposedly deals with clinics in Arizona, Florida and Ohio and were told there were other deals based on THOSE DEALS being made and yet we haven't heard anything on those deals. We have an IPO that is supposedly going on that Dawson James will not tell us anything on, yet the CEO (Joe Mascato of Generex / NGIO) tells us to contact them for information to go to because he has told us he can't.
We should have seen some type of revenue generated from clinics at the very least and yet, we see stock being dumped into the market.
All of the above is old news and yet we can't get updates on any of it. Not a shred of new information on any of it. We have no clue where any of it stands officially. This isn't an SEC issue or an FDA issue. This is a company issue. This is an issue with the Management not doing things right.
Joe said the IPO for NGIO would be the cleanest IPO. Well, what exactly is clean to Joe? Joe said he cares so much for his shareholders? How is any of this taking care of his shareholders? One of the responsibilities for the CEO is to bring value to the company, where is that value? The value of the company is literally shrinking every day. Every day.
Image is everything, and the image of Generex / NGIO does not look good. Maybe they are doing things behind the scenes. But from the surface, this looks like a disaster and the management is not helping anything the image at all.
Now, we are hitting the 52 week low. Still waiting on news from a company that hasn't been forthcoming on any initiatives in months.
We have over a 1 billion dollar deal with China. We have another 1 billion dollar deal in Malaysia. We have supposedly deals for Excellagen. We have supposedly deals with clinics in Arizona, Florida and Ohio and were told there were other deals based on THOSE DEALS being made and yet we haven't heard anything on those deals. We have an IPO that is supposedly going on that Dawson James will not tell us anything on, yet the CEO (Joe Mascato of Generex / NGIO) tells us to contact them for information to go to because he has told us he can't.
We should have seen some type of revenue generated from clinics at the very least and yet, we see stock being dumped into the market.
All of the above is old news and yet we can't get updates on any of it. Not a shred of new information on any of it. We have no clue where any of it stands officially. This isn't an SEC issue or an FDA issue. This is a company issue. This is an issue with the Management not doing things right.
Joe said the IPO for NGIO would be the cleanest IPO. Well, what exactly is clean to Joe? Joe said he cares so much for his shareholders? How is any of this taking care of his shareholders? One of the responsibilities for the CEO is to bring value to the company, where is that value? The value of the company is literally shrinking every day. Every day.
Image is everything, and the image of Generex / NGIO does not look good. Maybe they are doing things behind the scenes. But from the surface, this looks like a disaster and the management is not helping anything the image at all.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼